Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 50090-7294

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 50090-7294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Picture 1 (Image 01)

Picture 1 (Image 01)
Chemical structure diagram depicting the molecular structure of Lisinopril and Hydrochlorothiazide, showing atoms, bonds, and hydration with 2 water molecules (2H2O).*
FDA Label Image

Picture 2 (Image 02)

Picture 2 (Image 02)
Chemical structure of Lisinopril and Hydrochlorothiazide, illustrating the molecular arrangement of this active pharmaceutical ingredient combination used in oral tablet form.*
FDA Label Image

Label Image (Lbl500907294)

Label Image (Lbl500907294)
Label for Lisinopril and Hydrochlorothiazide Tablets USP 20 mg / 25 mg by A-S Medication Solutions, featuring dosage strength, storage instructions to protect from heat and humidity, quantity of 90 tablets, and barcode for scanning. The label includes the product NDC 50090-7294-0 and packaging location in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.